Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$482M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$460M |
| 3 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$294M |
| 4 |
Tesla
TSLA
|
+$276M |
| 5 |
Caterpillar
CAT
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 3 |
Lowe's Companies
LOW
|
+$663M |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$404M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.68% |
| 2 | Healthcare | 6.62% |
| 3 | Financials | 5.53% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
iShares Latin America 40 ETF
ILF
$3.73B
| $2.69M | ﹤0.01% |
117,600
+8,723
| +8% | +$217K |
|
1802
Elanco Animal Health
ELAN
$13.2B
| $2.69M | ﹤0.01% |
219,765
-214,021
| -49% | -$2.67M |
|
1803
CALL
CrowdStrike
CRWD
$183B
| $2.68M | ﹤0.01% |
102,000
-60,000
| -37% | -$2.05M |
|
1804
Emcor
EME
$29.9B
| $2.68M | ﹤0.01% |
18,094
-5,917
| -25% | -$840K |
|
1805
iShares MSCI United Kingdom ETF
EWU
$4.1B
| $2.68M | ﹤0.01% |
87,262
-49,834
| -36% | -$1.46M |
|
1806
Merit Medical Systems
MMSI
$4.82B
| $2.67M | ﹤0.01% |
37,817
+5,769
| +18% | +$385K |
|
1807
Opko Health
OPK
$1.02B
| $2.67M | ﹤0.01% |
2,132,483
-9,909
| -0.5% | -$15.6K |
|
1808
Innovative Industrial Properties
IIPR
$1.77B
| $2.66M | ﹤0.01% |
26,255
+1,242
| +5% | +$132K |
|
1809
Idacorp
IDA
$8B
| $2.66M | ﹤0.01% |
24,625
-6,458
| -21% | -$669K |
|
1810
Badger Meter
BMI
$3.87B
| $2.65M | ﹤0.01% |
24,282
+1,151
| +5% | +$125K |
|
1811
Casey's General Stores
CASY
$32.1B
| $2.65M | ﹤0.01% |
11,792
-1,345
| -10% | -$306K |
|
1812
CALL
Upstart Holdings
UPST
$2.55B
| $2.64M | ﹤0.01% |
200,000
| – | – |
|
1813
Agios Pharmaceuticals
AGIO
$2.08B
| $2.64M | ﹤0.01% |
94,159
-33,761
| -26% | -$951K |
|
1814
CALL
Ralph Lauren
RL
$22.4B
| $2.64M | ﹤0.01% |
+25,000
| New | +$2.5M |
|
|
EVOP
1815
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $2.64M | ﹤0.01% |
77,936
-15,002
| -16% | -$504K |
|
1816
Rocket Pharmaceuticals
RCKT
$343M
| $2.63M | ﹤0.01% |
134,554
-202,411
| -60% | -$3.73M |
|
1817
PUT
Rhythm Pharmaceuticals
RYTM
$7.31B
| $2.62M | ﹤0.01% |
90,000
| – | – |
|
1818
Arcus Biosciences
RCUS
$3.33B
| $2.62M | ﹤0.01% |
126,681
-108,002
| -46% | -$2.97M |
|
1819
Genworth Financial
GNW
$3.86B
| $2.62M | ﹤0.01% |
494,627
+66,755
| +16% | +$314K |
|
|
SAGE
1820
CALL
DELISTED
Sage Therapeutics
SAGE
| $2.62M | ﹤0.01% |
68,600
+48,600
| +243% | +$1.86M |
|
1821
Gossamer Bio
GOSS
$101M
| $2.62M | ﹤0.01% |
1,205,545
+130,448
| +12% | +$1.07M |
|
1822
Signet Jewelers
SIG
$3.84B
| $2.61M | ﹤0.01% |
38,446
+9,576
| +33% | +$610K |
|
1823
PUT
Sea Limited
SE
$66.4B
| $2.6M | ﹤0.01% |
50,000
-100,000
| -67% | -$5.39M |
|
1824
Prestige Consumer Healthcare
PBH
$2.47B
| $2.6M | ﹤0.01% |
41,487
+3,953
| +11% | +$227K |
|
1825
Lincoln Electric
LECO
$14.1B
| $2.59M | ﹤0.01% |
17,899
-13,278
| -43% | -$1.86M |
|
Similar funds
Citigroup's Q4 2022 Portfolio in Review
As of Q4 2022, Citigroup held 6,223 positions worth $126B, down 10% from $140B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Citigroup withdrew a net $21.4B in Q4 2022, closing 469 positions and reducing 2,674 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $404M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Consumer Staples Momentum ETF worth $21.5M.
- Citigroup's largest Q4 2022 buy was Invesco Dorsey Wright Consumer Staples Momentum ETF: 260,000 shares worth $21.5M.
- Citigroup added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2022, an estimated $482M increase.
- Citigroup's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.79B.
- Citigroup fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $404M.
- Citigroup's ten largest holdings make up 26% of its $126B portfolio in Q4 2022.
- Citigroup opened 309 new positions and closed 469 in Q4 2022.
- Citigroup's portfolio value fell 10% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.